These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential. Wong TN; Miller CA; Jotte MRM; Bagegni N; Baty JD; Schmidt AP; Cashen AF; Duncavage EJ; Helton NM; Fiala M; Fulton RS; Heath SE; Janke M; Luber K; Westervelt P; Vij R; DiPersio JF; Welch JS; Graubert TA; Walter MJ; Ley TJ; Link DC Nat Commun; 2018 Jan; 9(1):455. PubMed ID: 29386642 [TBL] [Abstract][Full Text] [Related]
4. PPM1D in Solid and Hematologic Malignancies: Friend and Foe? Zhang L; Hsu JI; Goodell MA Mol Cancer Res; 2022 Sep; 20(9):1365-1378. PubMed ID: 35657598 [TBL] [Abstract][Full Text] [Related]
5. Mutant Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma. Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603 [TBL] [Abstract][Full Text] [Related]
7. Potentiality of Protein phosphatase Mg Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183 [TBL] [Abstract][Full Text] [Related]
8. Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma. Yan C; Richard MA; Gibson CJ; He J; Bosworth A; Crossman DK; Singh P; Hageman L; Kalra R; Armenian SH; Vose J; Weisdorf DJ; Ebert BL; Yasui Y; Forman SJ; Bhatia R; Bhatia S J Clin Oncol; 2024 Jul; 42(20):2415-2424. PubMed ID: 38635938 [TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis with Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752 [TBL] [Abstract][Full Text] [Related]
10. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia. Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668 [TBL] [Abstract][Full Text] [Related]
14. Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Zhang CRC; Nix D; Gregory M; Ciorba MA; Ostrander EL; Newberry RD; Spencer DH; Challen GA Exp Hematol; 2019 Dec; 80():36-41.e3. PubMed ID: 31812712 [TBL] [Abstract][Full Text] [Related]
15. Targeting Immune Signaling Pathways in Clonal Hematopoiesis. Azrakhsh NA; Mensah-Glanowska P; Sand K; Kittang AO Curr Med Chem; 2019; 26(28):5262-5277. PubMed ID: 30907306 [TBL] [Abstract][Full Text] [Related]
16. Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy. Kim B; Won D; Lee ST; Choi JR PLoS One; 2019; 14(6):e0217521. PubMed ID: 31242196 [TBL] [Abstract][Full Text] [Related]
17. Clonal Hematopoiesis and therapy related MDS/AML. Desai P; Roboz GJ Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970 [TBL] [Abstract][Full Text] [Related]
18. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)? Steensma DP Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699 [TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Zink F; Stacey SN; Norddahl GL; Frigge ML; Magnusson OT; Jonsdottir I; Thorgeirsson TE; Sigurdsson A; Gudjonsson SA; Gudmundsson J; Jonasson JG; Tryggvadottir L; Jonsson T; Helgason A; Gylfason A; Sulem P; Rafnar T; Thorsteinsdottir U; Gudbjartsson DF; Masson G; Kong A; Stefansson K Blood; 2017 Aug; 130(6):742-752. PubMed ID: 28483762 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of C-terminal truncated PPM1D enhances the effect of doxorubicin on cell viability in human colorectal carcinoma cell line. Kozakai Y; Kamada R; Kiyota Y; Yoshimura F; Tanino K; Sakaguchi K Bioorg Med Chem Lett; 2014 Dec; 24(24):5593-5596. PubMed ID: 25466181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]